GHPharm
Korean company focused on research, development and commercialization of natural-product formulations derived from fern root/rhizome extracts. Documented activities include extraction and detoxification of plant material, isolation and characterization of small-molecule derivatives, in vitro antiviral screening, enzyme-inhibition and blood–brain barrier studies relevant to neurodegeneration, rodent efficacy models including hair-growth studies, analytical verification of toxin removal, patent filing, academic collaborations, and development and sale of liquid single-dose supplement/beverage formulations. Several peer-reviewed publications and patent filings are cited in site press material.
Industries
Nr. of Employees
small (1-50)
GHPharm
Products
Pterosin-derivative liquid supplement (single-dose sachets; beverage formulations)
Liquid oral supplement formulated from processed fern root/rhizome extracts containing identified small-molecule derivatives; offered in 70 ml single-dose sachets, with sugar-free variants and related beverage/tea formulations described in site materials.
Pterosin-derivative liquid supplement (single-dose sachets; beverage formulations)
Liquid oral supplement formulated from processed fern root/rhizome extracts containing identified small-molecule derivatives; offered in 70 ml single-dose sachets, with sugar-free variants and related beverage/tea formulations described in site materials.
Services
Joint preclinical and early translational research projects with university laboratories and regional bio centers.
Joint preclinical and early translational research projects with university laboratories and regional bio centers.
Expertise Areas
- Natural product extraction and small-molecule isolation
- Preclinical in vivo efficacy testing (rodent hair-growth models)
- In vitro antiviral and cell-based screening
- Enzyme inhibition profiling for neurodegeneration targets
Key Technologies
- Small-molecule natural product isolation and purification
- In vitro cell-based antiviral assays (Vero cells)
- Enzyme inhibition assays (including BACE1 and cholinesterases)
- Rodent in vivo efficacy models (hair-growth assays)
News & Updates
Press coverage and site summary report topical application of a purified fern-derived small-molecule derivative produced 80–100% hair regrowth in a rodent model, comparable to a marketed positive control.
Coverage of research showing inhibition of BACE1 and cholinesterases and reporting blood–brain barrier permeability for extracted small-molecule derivatives; work cited as published in Experimental & Molecular Medicine.
Multiple press reports on discovery of neuroprotective and hair-growth activities from fern extracts
Aggregated news articles describe discovery of compounds with activity in Alzheimer’s-related enzyme assays and hair-growth models, related patent filings, and early translational work.
Site-referenced coverage notes domestic and US patent filings and reports preparations for clinical trials in additional jurisdictions (reported preparations in China).
Research on fern-derived small-molecule derivatives and enzyme inhibition reported in a peer-reviewed journal in the field of experimental and molecular medicine.
Patent applications filed covering compositions and uses of active derivatives isolated from fern root/rhizome extracts; publications note domestic and US filings and ongoing international filings/preparations.
Press coverage and site summary report topical application of a purified fern-derived small-molecule derivative produced 80–100% hair regrowth in a rodent model, comparable to a marketed positive control.
Coverage of research showing inhibition of BACE1 and cholinesterases and reporting blood–brain barrier permeability for extracted small-molecule derivatives; work cited as published in Experimental & Molecular Medicine.
Multiple press reports on discovery of neuroprotective and hair-growth activities from fern extracts
Aggregated news articles describe discovery of compounds with activity in Alzheimer’s-related enzyme assays and hair-growth models, related patent filings, and early translational work.
Site-referenced coverage notes domestic and US patent filings and reports preparations for clinical trials in additional jurisdictions (reported preparations in China).
Research on fern-derived small-molecule derivatives and enzyme inhibition reported in a peer-reviewed journal in the field of experimental and molecular medicine.
Patent applications filed covering compositions and uses of active derivatives isolated from fern root/rhizome extracts; publications note domestic and US filings and ongoing international filings/preparations.